Prescient Therapeutics Ltd has released a press release.
Placement Results
Filed with ASX ·
On 6ix: 6ix.com/news/placement-results
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Story so far
Earlier from Prescient Therapeutics
- SPP Results and Placement
- PTX unveils CellPryme-A to boost CAR-T performance
- PTX strategic collaboration with MD Anderson Cancer Center
- Prescient Therapeutics Launches Share Purchase Plan
- Appendix 4E and 2022 Annual Report
Later from Prescient Therapeutics
- PTX-100 Trial Update
- September 2022 Quarterly Update and Appendix 4C
- AGM Presentation
- December 2022 Quarterly Update and Appendix 4C
- FDA grants broader orphan drug status to PTX100 for TCLs
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics